Certara Inc at Stephens Investment Conference Transcript
All right. Welcome again to everyone to day 3 of the Stephens Investment Conference. I'm Jeff Garro, the healthcare IT analyst here at Stephens, and I'm very happy to welcome Andrew Schemick and Ron DiSantis, from Certara here to the conference. Andrew is the CFO; and Ron is the SVP of Corporate Development. So thanks again for joining us, guys. And I'll just jump right into the questions.
Questions & Answers
And Andrew, I know some people in the audience might not know much more about Certara other than it's a leader in biosimulation. So I was hoping you could start us off with a high-level description of what biosimulation is and why it's an interesting and valuable tool for biopharma companies to deploy, and maybe to throw one more prompt in there, why Certara is viewed as a leader in the field?
Okay. Thank you. I appreciate the invitation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |